开发和应用PBPK建模策略,以支持抗疟疾药物开发
Nada Abla1, Eleanor Howgate2, Karen Rowland-Yeo2
1Medicines for Malaria Venture, Geneva, Switzerland.
CPT: pharmacometrics & systems pharmacology
|August 17, 2023
概括
为20种抗疟药物开发了基于生理学上的药理动力学 (PBPK) 模型,并在药物开发中使用了超过五年. 这项工作强调了PBPK建模对抗疟疾研究和决策的好处.
科学领域:
- 药理动力学 药理动力学
- 药物开发 药物开发
- 疟疾研究 疟疾研究
背景情况:
- 基于生理学的药理动力学 (PBPK) 模型是药物开发中的关键工具.
- 抗疟疾药物开发需要强大的药理动力学数据,以确保有效性和安全性.
- 为了开发抗疟疾药物的PBPK模型,进行了合作.
研究的目的:
- 为20种抗疟药物开发和验证PBPK模型.
- 展示在抗疟疾药物开发中使用PBPK模型的实际应用和不断发展的战略.
- 为全球卫生研究社区提供PBPK模型和案例研究的共享资源.
主要方法:
- 使用体外测定数据和基于文献的临床研究开发PBPK模型.
- 在Malaria Venture (MMV) 的抗疟疾药物开发管道中应用PBPK模型.
- 对抗疟疾联合疗法的药物相互作用责任的分析.
主要成果:
- 成功开发了20种抗疟药的PBPK模型,供研究人员使用.
- 这些模型在MMV的抗疟疾药物开发中经过五年的有效应用.
- 案例研究展示了开发和临床决策中的现实应用,包括药物相互作用评估.
结论:
- PBPK建模显著有利于抗疟疾药物开发和决策过程.
- 已经建立了将PBPK建模整合到研发中的战略方法.
- 开发的PBPK模型和相关信息作为全球健康研究的宝贵存储库.
相关概念视频
Physiological Pharmacokinetic Models: Incorporating Hepatic Transporter-Mediated Clearance
61
Drug transporters are critical in drug absorption, distribution, and excretion processes. They should be included in physiological-based pharmacokinetic (PBPK) models, which help predict human drug disposition. However, predicting this is challenging during drug development, especially when liver transport is involved. However, with a realistic representation of body transport processes, an accurate model may be possible.
A recent model describes pravastatin's hepatobiliary excretion,...
A recent model describes pravastatin's hepatobiliary excretion,...
61
Pharmacokinetic Models: Comparison and Selection Criterion
104
Physiological and compartmental models are valuable tools used in studying biological systems. These models rely on differential equations to maintain mass balance within the system, ensuring an accurate representation of the dynamic processes at play.
Physiological models take a detailed approach by considering specific molecular processes. They can predict drug distribution, metabolism, and elimination changes, providing a comprehensive understanding of how drugs interact with the body.
Physiological models take a detailed approach by considering specific molecular processes. They can predict drug distribution, metabolism, and elimination changes, providing a comprehensive understanding of how drugs interact with the body.
104
Analysis of Population Pharmacokinetic Data
293
Analysis of population pharmacokinetic data involves studying the behavior of drugs within diverse populations to understand their pharmacokinetic parameters. Traditional pharmacokinetic methods typically involve collecting samples from a few individuals and estimating these parameters. While these methods are commonly used, they have limitations in capturing the variability in drug response among individuals or heterogeneous populations. Population pharmacokinetics is employed to address these...
293
Pharmacokinetic Models: Overview
782
Pharmacokinetic models utilize mathematical analysis to achieve a detailed quantitative understanding of a drug's life cycle within the body. They are instrumental in simulating a drug's pharmacokinetic parameters, predicting drug concentrations over time, optimizing dosage regimens, linking concentrations with pharmacologic activity, and estimating potential toxicity.
There are three primary types of models: empirical, compartment, and physiological. Empirical models, with minimal...
There are three primary types of models: empirical, compartment, and physiological. Empirical models, with minimal...
782
Model Approaches for Pharmacokinetic Data: Distributed Parameter Models
96
Pharmacokinetic models are mathematical constructs that represent and predict the time course of drug concentrations in the body, providing meaningful pharmacokinetic parameters. These models are categorized into compartment, physiological, and distributed parameter models.
The distributed parameter models are specifically designed to account for variations and differences in some drug classes. This model is particularly useful for assessing regional concentrations of anticancer or...
The distributed parameter models are specifically designed to account for variations and differences in some drug classes. This model is particularly useful for assessing regional concentrations of anticancer or...
96
Analysis Methods of Pharmacokinetic Data: Model and Model-Independent Approaches
179
Drug disposition in the body is a complex process and can be studied using two major approaches: the model and the model-independent approaches.
The model approach uses mathematical models to describe changes in drug concentration over time. Pharmacokinetic models help characterize drug behavior in patients, predict drug concentration in the body fluids, calculate optimum dosage regimens, and evaluate the risk of toxicity. However, ensuring that the model fits the experimental data accurately...
The model approach uses mathematical models to describe changes in drug concentration over time. Pharmacokinetic models help characterize drug behavior in patients, predict drug concentration in the body fluids, calculate optimum dosage regimens, and evaluate the risk of toxicity. However, ensuring that the model fits the experimental data accurately...
179


